Enhancing the safety and efficacy of cell therapy with programmed sense-and-respond function

Andrew J. Walters; Xiaoyu Yang; Scott D. Olson; Caleb J. Bashor

doi:10.1002/ctm2.70328

Clinical and Translational Medicine ›› 2025, Vol. 15 ›› Issue (5) : e70328 DOI: 10.1002/ctm2.70328

INVITED LETTER

Enhancing the safety and efficacy of cell therapy with programmed sense-and-respond function

Author information +

History +

PDF

Cite this article

Download citation ▾

Andrew J. Walters, Xiaoyu Yang, Scott D. Olson, Caleb J. Bashor. Enhancing the safety and efficacy of cell therapy with programmed sense-and-respond function. Clinical and Translational Medicine, 2025, 15(5): e70328 DOI:10.1002/ctm2.70328

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Bashor CJ, Hilton IB, Bandukwala H, Smith DM, Veiseh O. Engineering the next generation of cell-based therapeutics. Nat Rev Drug Discov. 2022; 21: 655-675.

[2]	Cox DB, Platt RJ, Zhang F. Therapeutic genome editing: prospects and challenges. Nat Med. 2015; 21: 121-131.

[3]	Schambach A, Buchholz CJ, Torres-Ruiz R, et al. A new age of precision gene therapy. Lancet. 2024; 403: 568-582.

[4]	June CH, O'Connor RS, Kawalekar OU, Ghassemi S, Milone MC. CAR T cell immunotherapy for human cancer. Science. 2018; 359: 1361-1365.

[5]	Lim WA, June CH. The principles of engineering immune cells to treat cancer. Cell. 2017; 168: 724-740.

[6]	Di Stasi A, Tey SK, Dotti G, et al. Inducible apoptosis as a safety switch for adoptive cell therapy. N Engl J Med. 2011; 365: 1673-1683.

[7]	Roybal KT, Rupp LJ, Morsut L, et al. Precision tumor recognition by T cells with combinatorial antigen-sensing circuits. Cell. 2016; 164: 770-779.

[8]	Yang X, Rocks JW, Jiang K, et al. Engineering synthetic phosphorylation signaling networks in human cells. Science. 2025; 387: 74-81.

[9]	Teng F, Cui T, Zhou L, Gao Q, Zhou Q, Li W. Programmable synthetic receptors: the next-generation of cell and gene therapies. Signal Transduct Target Ther. 2024; 9: 7.

[10]	Galvan S, Teixeira AP, Fussenegger M. Enhancing cell-based therapies with synthetic gene circuits responsive to molecular stimuli. Biotechnol Bioeng. 2024; 121: 2987-3000.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.